Surevest’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
$30K Hold
494
0.01% 216
2022
Q2
$31K Hold
494
0.01% 233
2022
Q1
$29K Hold
494
0.01% 214
2021
Q4
$36K Buy
+494
New +$34K 0.01% 205
2020
Q2
Sell
-7,335
Closed -$548K 89
2020
Q1
$548K Sell
7,335
-13,914
-65% -$961K 0.3% 68
2019
Q4
$1.38M Sell
21,249
-713
-3% -$46.4K 0.59% 81
2019
Q3
$1.39M Buy
21,962
+1,435
+7% +$93.8K 0.69% 64
2019
Q2
$1.39M Buy
20,527
+9,196
+81% +$605K 0.72% 46
2019
Q1
$737K Buy
11,331
+6,116
+117% +$407K 0.45% 66
2018
Q4
$326K Buy
+5,215
New +$365K 0.26% 75

Other funds holding GILD

Surevest's GILD Position: Q3 2022 in Review

Surevest held its Gilead Sciences (GILD) position steady in Q3 2022 at 494 shares worth $30K. The position accounts for 0.01% of the portfolio, ranked #216.

Surevest first reported a position in GILD in Q4 2018 and has held it in 10 quarters since. The position peaked at $1.39M in Q3 2019. 1,602 funds tracked by Wall St. Rank hold GILD as of Q3 2022.

  • Surevest held 494 shares of Gilead Sciences worth $30K as of Q3 2022.
  • Surevest left its Gilead Sciences share count unchanged in Q3 2022.
  • Gilead Sciences made up 0.01% of Surevest's portfolio in Q3 2022, its #216 holding.
  • Surevest first reported a position in Gilead Sciences in Q4 2018 and has held it in 10 quarters since.
  • Surevest's Gilead Sciences position peaked at $1.39M in Q3 2019.
  • 1,602 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2022.

Based on Surevest's 13F filing for Q3 2022, filed 14 Nov 2022.